United States · 
Who invested in Careviso?
Careviso's investors include Mercury Fund.
United States · Series B startup
Who invested in Careviso
Funding summaryUpdated 26 Oct 2026
$17Mraised across 1 round since 2022, from 1 source
- Latest round
- Series B, $17MSept 2022
- Investors
- 1
The rounds
- Sept 2022
Founders and team
From Careviso's own website and the SEC filings it signed: 2 founders, 10 on the team.
- Dave HaffnerChief Financial Officer
- Rachelle GalantChief Strategy Officer
- John PavlovichChief Operating Officer
- Jack KellyVP of Product
- Kari TimothyVP of Commercial Operations
- Sam LeslieVP of Engineering
- Shauna HayVP of Clinical Operations
- Tom BavinVP of seeQer Operations
- Wendy JohnsonVP of Life Sciences
- Jim HarriotExecutive Officeri
On the board, as filediAziz GilaniDavid HarringtonDennis SmithLucas NelsonMatt Rice
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Careviso as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Careviso
How much has Careviso raised?
Careviso has raised $17M across 1 round since 2022.
When did Careviso last raise?
Careviso's most recent round was a Series B of $17M in Sept 2022.
What was Careviso's biggest round?
Its most recent round, $17M in Sept 2022, is also its largest on record.
Who backed Careviso first?
Careviso's first round on record, in Sept 2022, was backed by Mercury Fund.
What stage is Careviso at?
Careviso's latest named round is a Series B, in Sept 2022.
Where is Careviso based?
Careviso is based in the United States.
Companies like Careviso
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.